Many oncologist do this on a regular basis!!! By making 👆 statement, you are basically saying that oncologist don’t go the extra way. We do, insurance companies are just not being held accountable.
#ASHKUDOS to all of our partners at home who are holding down the home front all alone while we get to enjoy #ASH23.
This is my rockstar hubby making rotti (Indian bread) for my kiddos in different shapes.
Excellent use of real-world data
Confirms previous smaller data fairly conclusively
n=2,522, 36.8% twice a week bortezomib, 63.2% once week
No difference in efficacy outcomes (even though high-risk was more likely to be given twice week)
tinyurl.com/yn49z78v#mmsm#ASH23
1/ So excited to see this out!
nature.com/articles/s4140…
In myeloma, trials continue to use 2x weekly bortezomib because of a belief that standard of care (SOC) is only based on older trials.
In reality, the SOC is how typical physicians would approach #MMsm care - so we asked!
Analysis of 939 myeloma pts #mmsm pts w/ self-id ethnicity – NHW (169,18%) NHB (489, 52%), Hispanics (281,30%) from the BRONX & showed that Hisp have equal if not better outcomes when given access to novel tx and ASCT. Our results were validated w/ the Connect registry. 1/
Last get together before we part ways #IMS23. We have known each other since we were intern babies @TuftsMedicalCtr only to realize we will end up in same field! Now every meeting is a reflection on how much we have grown! #mmsm